20451-50-7

Basic information

• Product Name: Cyclohexanecarbonyl chloride, 4-(1,1-dimethylethyl)-
• CAS NO: 20451-50-7
• Molecular Formula: C11H19ClO
• Molecular Weight: 202.724
• Mol File: 20451-50-7.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Cyclohexanecarbonyl chloride, 4-(1,1-dimethylethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanecarbonyl chloride, 4-(1,1-dimethylethyl)-(20451-50-7)
• EPA Substance Registry System: Cyclohexanecarbonyl chloride, 4-(1,1-dimethylethyl)-(20451-50-7)

Safety Data

• Hazardous Substances Data: 20451-50-7(Hazardous Substances Data)

Upstream product

• 5451-55-8 4-tert-butylcyclohexanecarboxylic acid 

Downstream Products

• 174271-42-2 trans-4-tert-butyl-N-allylcyclohexanecarboxamide 
• 1037834-23-3 1-{1-[2-(4-tert-butylcyclohexyl)-2-oxoethyl]piperidin-4-yl}-6-fluoro-N-methyl-2-oxo-2,3-dihydro-1H-benzimidazole-5-carboxamide 
• 1037835-07-6 1-{1-[2-(4-tert-butylcyclohexyl)-2-oxoethyl]piperidin-4-yl}-5-(methylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one 
• 1037834-21-1 4-(t-butyl)cyclohexyl α-chloromethyl ketone 
• 477879-70-2 4-tert-butyl-N-[1-(3-tert-butyl-5-oxo-4,5-dihydro-1,2,4-triazin-6-yl)propyl]cyclohexanecarboxamide 
• 477879-69-9 4-tert-butyl-N-[1-(3-cyclopentyl-5-oxo-4,5-dihydro-1,2,4-triazin-6-yl)propyl]cyclohexanecarboxamide 
• 477879-68-8 4-tert-butyl-N-[1-(3-cyclopropyl-5-oxo-4,5-dihydro-1,2,4-triazin-6-yl)propyl]cyclohexanecarboxamide 
• 477879-67-7 N-{1-[3-(3-bromophenyl)-5-oxo-4,5-dihydro-1,2,4-triazin-6-yl]propyl}-4-tert-butyl-cyclohexanecarboxamide 
• 863769-04-4 4-tert-butyl-cyclohexanecarboxylic acid pyridin-4-ylamide 
• 84856-21-3 Benzenesulfonic acid 2-(4-tert-butyl-cyclohexyl)-2-oxo-ethyl ester 

Relevant articles and documents

Diastereoselection in the Decarboxylation Reaction. Effect of Nonbonded Ring Oxygens in the Reactions of Geminal Diesters

-

Nitrile group containing phenyl trans-cyclohexane amide compound and use thereof

The invention belongs to the field of medicines associated with thrombotic diseases, and particularly relates to a nitrile group and phenyl group-containing PAR-1 (pretease activated receptor-1) antagonist and application of antagonist in preparation of medicines for treating thrombotic diseases, wherein the nitrile group and phenyl group-containing PAR-1 antagonist has a structure of a formula (I) as shown in the specification.

Synthesis of new chiral pyrylium salts and their phosphinine and pyridine derivatives

Despite their versatility, chiral pyryliums are almost unknown in the literature. Reported here is the synthesis of several new chiral pyrylium salts and the corresponding pyridines and phosphinines. This work more than doubles the number of reported chir